174 related articles for article (PubMed ID: 1892302)
1. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.
Kips JC; Joos GF; De Lepeleire I; Margolskee DJ; Buntinx A; Pauwels RA; Van der Straeten ME
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):617-21. PubMed ID: 1892302
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
Manning PJ; Watson RM; Margolskee DJ; Williams VC; Schwartz JI; O'Byrne PM
N Engl J Med; 1990 Dec; 323(25):1736-9. PubMed ID: 2174121
[TBL] [Abstract][Full Text] [Related]
3. Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.
Gaddy JN; Margolskee DJ; Bush RK; Williams VC; Busse WW
Am Rev Respir Dis; 1992 Aug; 146(2):358-63. PubMed ID: 1489125
[TBL] [Abstract][Full Text] [Related]
4. Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma.
Wahedna I; Wisniewski AS; Tattersfield AE
Br J Clin Pharmacol; 1991 Oct; 32(4):512-5. PubMed ID: 1958449
[TBL] [Abstract][Full Text] [Related]
5. The effect of aerosolized SK&F 104353-Z2 on the bronchoconstrictor effect of leukotriene D4 in asthmatics.
Joos GF; Kips JC; Pauwels RA; Van der Straeten ME
Pulm Pharmacol; 1991; 4(1):37-42. PubMed ID: 1804493
[TBL] [Abstract][Full Text] [Related]
6. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
De Lepeleire I; Reiss TF; Rochette F; Botto A; Zhang J; Kundu S; Decramer M
Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.
Smith LJ; Geller S; Ebright L; Glass M; Thyrum PT
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):988-92. PubMed ID: 2158260
[TBL] [Abstract][Full Text] [Related]
8. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
O'Shaughnessy TC; Georgiou P; Howland K; Dennis M; Compton CH; Barnes NC
Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma.
Rasmussen JB; Eriksson LO; Margolskee DJ; Tagari P; Williams VC; Andersson KE
J Allergy Clin Immunol; 1992 Aug; 90(2):193-201. PubMed ID: 1323587
[TBL] [Abstract][Full Text] [Related]
10. Asthmatic airways have a disproportionate hyperresponsiveness to LTE4, as compared with normal airways, but not to LTC4, LTD4, methacholine, and histamine.
Arm JP; O'Hickey SP; Hawksworth RJ; Fong CY; Crea AE; Spur BW; Lee TH
Am Rev Respir Dis; 1990 Nov; 142(5):1112-8. PubMed ID: 2173457
[TBL] [Abstract][Full Text] [Related]
11. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.
Dahlén B; Kumlin M; Margolskee DJ; Larsson C; Blomqvist H; Williams VC; Zetterström O; Dahlén SE
Eur Respir J; 1993 Jul; 6(7):1018-26. PubMed ID: 8396534
[TBL] [Abstract][Full Text] [Related]
12. Exercise-induced refractoriness in asthmatic subjects involves leukotriene and prostaglandin interdependent mechanisms.
Manning PJ; Watson RM; O'Byrne PM
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):950-4. PubMed ID: 8214949
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219.
Kidney JC; Ridge SM; Chung KF; Barnes PJ
Am Rev Respir Dis; 1993 Jan; 147(1):215-7. PubMed ID: 8420421
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of leukotriene D4 inhalation challenge in asthmatics. Effect of a novel leukotriene D4/E4-antagonist (SR 2640) on leukotriene D4-induced bronchoconstriction.
Frølund L; Madsen F; Nielsen J
Allergy; 1991 Jul; 46(5):355-61. PubMed ID: 1928658
[TBL] [Abstract][Full Text] [Related]
15. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
Phillips GD; Rafferty P; Robinson C; Holgate ST
J Pharmacol Exp Ther; 1988 Aug; 246(2):732-8. PubMed ID: 3404455
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene (LT) D4 is involved in antigen-induced asthma: a study with the LTD4 receptor antagonist, MK-571.
Rasmussen JB; Margolskee DJ; Eriksson LO; Williams VC; Andersson KE
Ann N Y Acad Sci; 1991; 629():436. PubMed ID: 1952571
[No Abstract] [Full Text] [Related]
17. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.
Dahlén B; Margolskee DJ; Zetterström O; Dahlén SE
Thorax; 1993 Dec; 48(12):1205-10. PubMed ID: 8303624
[TBL] [Abstract][Full Text] [Related]
18. Leukotrienes C4, D4, and E4 enhance histamine responsiveness in asthmatic airways.
O'Hickey SP; Hawksworth RJ; Fong CY; Arm JP; Spur BW; Lee TH
Am Rev Respir Dis; 1991 Nov; 144(5):1053-7. PubMed ID: 1659268
[TBL] [Abstract][Full Text] [Related]
19. Effect of inhaled leukotriene D4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects.
Mulder A; Gauvreau GM; Watson RM; O'byrne PM
Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1562-7. PubMed ID: 10228127
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
Amirav I; Pawlowski N
N Engl J Med; 1991 May; 324(18):1288. PubMed ID: 1849613
[No Abstract] [Full Text] [Related]
[Next] [New Search]
